The Cellular Pharmacology of F-TAF in Dried Blood Spots
Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 18 Oct 2018
At a glance
- Drugs Emtricitabine/tenofovir alafenamide (Primary)
- Indications HIV-1 infections
- Focus Pharmacokinetics
- Acronyms TAF-DBS
- 09 Oct 2018 Status changed from recruiting to active, no longer recruiting.
- 09 Oct 2018 Planned End Date changed from 1 Mar 2019 to 1 Jun 2019.
- 09 Oct 2018 Planned primary completion date changed from 1 Mar 2019 to 1 Jun 2019.